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Abstract
Aims To estimate the risk of stroke in people with Type 2 diabetes with different blood pressure levels compared with
the risk in the general population in Sweden.
Methods This prospective case–control study included 408 076 people with Type 2 diabetes, aged ≥ 18 years, and free
of prior stroke, registered in the Swedish National Diabetes Register 1998–2011. Age- and sex-matched control subjects
(n = 1 913 507) without stroke from the general population were included. Stroke diagnoses were retrieved using
International Classification of Disease codes from the Swedish patient and death registers. Cox hazard ratios and 95%
confidence intervals (CIs) were estimated at six different blood pressure levels.

During a median follow-up of 4 years, 19 548 (4.8%) people with Type 2 diabetes and 61 690 (3.2%) without
diabetes were diagnosed with stroke, corresponding to an adjusted hazard ratio of 1.43 (95% CI 1.41–1.46) for people
with Type 2 diabetes as a group. Compared with people without diabetes, the risk of stroke for people with Type 2
diabetes with different blood pressure levels was significantly higher, starting at blood pressure levels > 130/80 mmHg.
Hazard ratios for stroke were 1.20 (95% CI 1.16–1.24), 1.47 (95% CI 1.43–1.50), and 1.97 (95% CI 1.90–2.03) for
blood pressure categories of 130–139/80–89 mmHg, 140–159/90–99 mmHg and ≥ 160/≥ 100 mmHg, respectively,
after adjustment for age, sex, diabetes duration, being born in Sweden, maximum education level and baseline
comorbidities.
Results

Conclusions People with Type 2 diabetes and blood pressure < 130/80 mmHg had a risk of stroke similar to that of the
general population.

Diabet. Med. 34, 522–530 (2017)

Introduction
Stroke is the second most common cause of death and a
common cause of disability worldwide [1,2]. Knowledge
regarding risk factors and their importance in different
groups is essential for preventive actions. People with Type
2 diabetes have a 1.5–3 times higher risk of stroke than
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people without diabetes [3], and often have several other
conventional risk factors for stroke, which further enhances
the risk. Hypertension is the most important risk factor for
stroke [4], with risk gradually increasing from blood
pressure levels below the limits for hypertension [5].
Numerous studies exclusively in people with Type 2
diabetes have shown that reducing blood pressure lowers
the risk of stroke [6,7].
Even though it is well documented that the risk of stroke is
elevated for people with Type 2 diabetes as a group, this may
not apply equally to all individuals with Type 2 diabetes.
Blood pressure and Type 2 diabetes may interact synergistically and greatly increase the stroke risk for people above a
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What’s new?
• Type 2 diabetes and blood pressure level are well
known predictors of stroke, but the risk of stroke for
people with Type 2 diabetes at different blood pressure
levels compared with the risk for the general population
is not known.
• We found that people with Type 2 diabetes and blood
pressure < 130/80 mmHg had a risk of any stroke
similar to that of the general population.
• People with Type 2 diabetes and blood pressure in the
range of 120–139/70–89 mmHg had a significantly
lower risk of haemorrhagic stroke compared with the
general population.
certain blood pressure level, which could result in an
increased risk for people with Type 2 diabetes as a group.
Large studies evaluating the risk of stroke in people with
Type 2 diabetes at different blood pressure levels compared
with the general population are sparse. Using the Swedish
National Diabetes Register (NDR), we conducted a large
observational case–control study in which we investigated
the risk of stroke at different blood pressure levels in people
with Type 2 diabetes and compared their risk with that of the
general Swedish population.

Patients and methods
People with and without diabetes

The NDR was initiated in 1996 as a nationwide instrument
for quality improvement in diabetes care, covering patients
aged ≥ 18 years. Annually, information on risk factors,
diabetes complications and medications is reported to the
register from the local care provider. The number of patients
in the register has increased since 1996 [8]. The NDR annual
report of 2013 estimated that 88% of all adults with diabetes
in Sweden were included in the register. In the NDR, Type 2
diabetes is defined as diabetes treated with diet only, oral
hypoglycaemic agents only or insulin only or in combination
with oral hypoglycaemic agents if onset of diabetes was at
age ≥ 40 years [9]. We identified a cohort of 435 660 people
with Type 2 diabetes registered at least once during 1998–
2011. For each individual with Type 2 diabetes, we
randomly selected five age-, sex- and county-matched controls from the Swedish Total Population Register, a method
used in previous studies [10,11], altogether 2 144 567
people. We excluded control subjects registered in the
NDR (394), people with Type 2 diabetes, those who died
before the start of the study (26 981), and people with Type
2 diabetes and control subjects with a diagnosis of stroke
registered before the start of the study (231 269). Finally, a
total of 408 076 people with and 1 913 507 without Type 2
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diabetes remained for analysis. Patients with Type 2 diabetes
and their matched controls entered the study on the day of
the first registration in the NDR, and were followed until first
hospitalization for stroke, until death, or until 31st of
December 2011.
Procedure

Information on stroke endpoints and comorbidities was
linked to our study from the Swedish National Patient
Register and Cause of Death Register via the personal
identification number, unique for every citizen in Sweden.
Likewise, information concerning place of birth and educational level were linked from the Longitudinal Integration
Database for Health Insurance and Labour Market Studies
register. For people with diabetes, data on risk factors,
medications and lifestyle were retrieved from the NDR; no
similar data were available for people without diabetes. After
matching, all personal identifiers were replaced by codes. All
patients in the NDR have agreed to be included in the
register. The study was approved by the regional ethics
review board at the University of Gothenburg.
Variables

All discharges from hospitals in Sweden are registered in the
Swedish National Patient Register, with principal and
contributory diagnoses recorded using the International
Classification of Disease (ICD) codes The register has had
nationwide coverage since 1987. All deaths are registered in
the Cause of Death Register. The positive predictive value for
discharge diagnoses in the hospital discharge register differs,
but is generally 85–95% for major cardiovascular diagnosis
categories [12]. In 2004, the two registers showed a
sensitivity for stroke diagnosis of 92% when combined [13].
The following diagnostic codes were used to identify
previous stroke: haemorrhagic stroke: 431, 432X (ICD-9),
I61, I62.9 (ICD-10); and ischaemic stroke: 433, 434, 436,
437X (ICD-9), I63, I64, I67.9 (ICD-10). To identify comorbidities at study entry, the following codes were used:
coronary heart disease 410-414 (ICD-9) I20-I25 (ICD-10);
atrial fibrillation 427D (ICD-9) I48 (ICD-10); and heart
failure 428 (ICD-9) I50 (ICD-10).
To define stroke endpoints, we used the following ICD-10
diagnoses: any stroke (I61, I62.9, I63, I64, I67.9); ischaemic
stroke (I63, I64, I67.9); and haemorrhagic stroke (I61,
I62.9).
Education was categorized as low (compulsory only),
intermediate or high (university or similar), and country of
birth as Sweden or other.
The standard for blood pressure measurement used in the
NDR is the mean value (mmHg) of two readings in the supine
position using a cuff of appropriate size and after at least
5 min of rest. People with Type 2 diabetes were categorized
into one of the following six predefined blood pressure
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categories: < 110/< 65 mmHg; 110–119/65–69 mmHg;
120–129/70–79 mmHg;
130–139/80–89 mmHg;
140–
159/90–99 mmHg; and ≥ 160/≥ 100 mmHg. Participants
with discordant systolic (SBP) and diastolic blood pressure
(DBP) were classified into the higher category. Laboratory
analyses of HbA1c and microalbuminuria were performed at
the local laboratory. All healthcare laboratory units in
Sweden are associated with a quality assessment organization
with regular validations. Healthcare units in Sweden used
HbA1c methods, which were calibrated to the high-performance liquid chromatography mono-S method until September 2010, when there was a national change in favour of the
calibration recommended by the International Federation of
Clinical Chemistry and Laboratory Medicine and the
National Glycohemoglobin Standardization Program
(NGSP). HbA1c values are reported as mmol/mol and
percentage, and were converted according to the NGSP
[14]. Microalbuminuria was defined as at least two positive
tests out of three taken within 1 year. Renal impairment was
categorized as normoalbuminuria, microalbuminuria [albumin/creatinine ratio of 3–30 mg/mmol (~ 30–300 mg/g) or
U-albumin of 20–200 lg/min (20–300 mg/l)], macroalbuminuria [albumin/creatinine ratio > 30 mg/mmol (> 300 mg/
g) or U-albumin > 200 lg/min (> 300 mg/l)] or stage 5
chronic renal disease (defined as the need for renal dialysis or
renal transplantation or as an estimated GFR < 15 ml/min).
Statistical analysis

Unadjusted incidence rates for stroke endpoints were estimated by exact Poisson confidence limits and presented as
events per 1000 person-years of follow-up with 95% CIs.
To study the relationship between people with Type 2
diabetes with different updated mean blood pressure and
stroke endpoints, three Cox regression models were constructed with people without diabetes as a reference.
Updated mean blood pressure was defined as the mean value
of all preceding measures and this was updated for each new
measurement (for example, when the third measurement
from baseline was performed, the updated mean blood
pressure was the mean of the three first measurements). The
mean number of blood pressure registrations used was four.
Only values recorded before the index stroke event or
censoring were used. Time at risk was calculated from the
date of entry of study to that of first admission to hospital
with a principal diagnosis of stroke, to death, or to 31
December 2011. Model 1 was an unadjusted model stratified
by match set (according to age and sex). Model 2 was
adjusted for time-updated age and sex, and stratified by
diabetes duration. Model 3 was additionally adjusted for
being born in Sweden or elsewhere, maximum education
level and comorbidities (atrial fibrillation, coronary heart
disease and heart failure) at baseline. In models 2 and 3 the
matching by set was not kept because we also wanted to
study the effect of age and sex on stroke events, and hence,
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they were included as covariates. In models 2 and 3 the risk
of stroke for each group of people with diabetes in a certain
blood pressure category was estimated against the risk of all
controls grouped together. Subgroup analyses on model 3
were performed to analyse the effect of sex, age group and
comorbid cardiovascular disease [diagnosis: I00-99 (ICD10)].
We also constructed Cox regression models to study the
relationship between blood pressure and stroke within the
group of people with Type 2 diabetes. The updated mean
blood pressure category of 120–129/70–79 mmHg was used
as a reference. Separate models for SBP and DBP categories
were also constructed. Hazard ratios (HRs) and associated
95% CIs for stroke were estimated in all Cox regression
models. All P values were two-sided and values < 0.05 were
taken to indicate statistical significance. The assumption of
the proportional hazard was tested for all Cox regression
analyses and was found to hold. All analyses were performed
using SAS software version 9.3.

Results
Baseline characteristics

People with Type 2 diabetes were less educated and less often
born in Sweden than people without diabetes (Table 1).
Blood pressure had a linear relationship with age in people
with Type 2 diabetes, 64% of whom received antihypertensive treatment (Table S1). Baseline comorbidities (coronary
heart disease, atrial fibrillation and heart failure) were more
common in people with Type 2 diabetes compared with
those without diabetes. The number of comorbid conditions
(coronary heart disease, heart failure and atrial fibrillation)
decreased with increasing blood pressure.

Incidence of stroke

The median follow-up in the study was 4.0 years and
4.1 years for people with and without Type 2 diabetes,
respectively. Out of 408 076 individuals with Type 2
diabetes, 19 548 (4.8%) received a diagnosis of stroke
compared with 61 690 out of 1 913 507 (3.2%) individuals
without diabetes; 13.8% were fatal within 28 days. The
unadjusted incidences of stroke according to blood pressure
category are shown in Figure 1. For people with Type 2
diabetes as a group, the incidence rate per 1000 person-years
was 10.63 for any stroke, 9.62 for ischaemic stroke and 1.01
for haemorrhagic stroke. Corresponding rates among people
without diabetes were 6.80, 5.92 and 0.88 cases per 1000
person-years, respectively.

Risk of stroke

The estimates from the Cox regression models are shown in
Fig. 1 and Table S2. In the final model with adjustment for
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Table 1 Characteristics of people with Type 2 diabetes at first
inclusion in the National Diabetes Register, 1998–2011, and of
controls, all free of previous stroke.

Women
Age, years (SD)
Born in Sweden
Education category
Low
Mid
High

Controls
N = 1 913 507

All type 2 diabetes
N = 408 076

869 045 (45.4%)
64.6 (12.5)
1 673 823 (87.5%)

182 486 (44.7%)
65.3 (12.6)
337 235 (82.6%)

682 929 (36.3%)
744 627 (39.6%)
453 805 (24.1%)

175 217 (43.9%)
160 153 (40.1%)
63 730 (16.0%)

Registrations in the National Patient Register prior to baseline
Coronary heart
137 957 (7.2%)
62 037 (15.2%)
disease (I20-I25)
Atrial fibrillation
89 814 (4.7%)
32 166 (7.9%)
(I48)
Heart failure (I50)
53 104 (2.8%)
25 986 (6.4%)
Variables in the National Diabetes Register only
Systolic blood
140.3 (18.3)
pressure, mmHg (SD)
n = 351 847
Diastolic blood
78.6 (9.8)
pressure, mmHg (SD)
n = 351 847
HbA1c, mmol/mol
54.3 (14.6),
(SD), NGSP % (SD)
7.1 (1.3)
n = 364 237
Diabetes duration, y
5.53 (6.96)
(SD)
n = 363 024
Antihypertensive
245 495 (64.0%)
treatment
Smoking, n (%)
51 153 (15.5%)

updated age, sex, stratified by diabetes duration, being born
in Sweden, maximum education level and baseline comorbidities, the HR of any stroke for people with Type 2
diabetes as a group was 1.43 (95% CI 1.41–1.46) compared
with people without diabetes. When the multiple-adjusted
risk was estimated for people with Type 2 diabetes at
different updated mean blood pressure levels, the risk was
significantly elevated in the three highest blood pressure
categories. The HRs of any stroke were 1.20 (95% CI 1.16–
1.24), 1.47 (95% CI 1.43–1.50) and 1.97 (95% CI 1.90–
2.03) for blood pressure categories of 130–139/80–
89 mmHg,
140–159/90–99 mmHg
and
≥ 160/
≥ 100 mmHg, respectively.
The multiple-adjusted HR for ischaemic stroke for people
with Type 2 diabetes as a group was 1.48 (95% CI 1.46–
1.51) compared with people without diabetes. The multipleadjusted risk of ischaemic stroke was only very slightly
elevated for people with Type 2 diabetes compared with
those without diabetes at blood pressure levels < 130/
80 mmHg. For blood pressure levels > 130/80 mmHg, the
HR for ischaemic stroke increased gradually to a maximum
HR of 2.02 (95% CI 1.96–2.09) in the blood pressure
category of ≥ 160/≥ 100 mmHg.
For haemorrhagic stroke, the multiple-adjusted HR for
people with Type 2 diabetes as a group was 1.08 (95% CI
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1.02–1.14) compared with people without diabetes, with a
significantly lower multiple-adjusted risk for people with
Type 2 diabetes compared with people without diabetes in
the blood pressure categories of 120–129/70–79 mmHg and
130–139/80–89 mmHg, with corresponding HRs of 0.66
(95% CI 0.55–0.79) and 0.87 (95% CI 0.78–0.97), respectively; however, people with Type 2 diabetes in the two
highest blood pressure categories had a significantly higher
risk of haemorrhagic stroke with a multiple-adjusted HR of
1.56 (95% CI 1.41–1.73) in the highest blood pressure
category. Figure 2 and Figs S1 and S2 show the results from
the analyses by sex, age group and circulatory comorbidities,
with essentially similar findings.

Analysis of people with Type 2 diabetes only

Table 2 and Tables S3 and S4 show the results from Cox
regression analysis with different adjustment models on
people with Type 2 diabetes only. The blood pressure
category of 120–129/70–79 mmHg was used as a reference.
For any stroke and ischaemic stroke, we found a J-shaped
association over the blood pressure categories, with a slightly
higher risk in the second lowest category, but paradoxically,
not the lowest, compared with the third blood pressure
category (reference). For haemorrhagic stroke, there was a
significant gradually increasing risk by each higher blood
pressure category above the reference. For any stroke and for
both ischaemic and haemorrhagic stroke, any blood pressure
of 130/80 mmHg or above was associated with significantly
increased risk in all models. Table S3 Model E (additionally
adjusted for antihypertensive treatment, smoking and timeupdated mean SBP/DBP) shows the increased risk for
ischaemic stroke by 1 SD mmHg which was for SBP 1.17
(95% CI 1.15–1.19) and for 1 SD mmHg DBP 1.11 (95% CI
1.09–1.13). Corresponding estimates for haemorrhagic
stroke were 1.16 (95% CI 1.09–1.22) for 1 SD mm Hg SBP
and 1.29 (95% CI 1.21–1.36) for 1 SD mmHg DBP (Table S4
Model E).

Discussion
In the present nationwide observational study, people with
Type 2 diabetes as a group had a higher risk of stroke
compared with an age- and sex-matched general population;
however, when we analysed the risk in different blood
pressure categories, we found no increased risk of stroke in
Type 2 diabetes if blood pressure was < 130/80 mmHg.
Above this level, the risk of any stroke rose gradually to a
maximum of an almost doubled risk in the highest category
compared with the general population.
The risk of ischaemic stroke was higher for people with
Type 2 diabetes compared with the general population in all
blood pressure categories. By contrast, those with Type 2
diabetes had a lower risk of haemorrhagic stroke compared
with the general population in some lower blood pressure
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FIGURE 1 Crude incidence of stroke, incidence rate ratios and adjusted hazard ratios (HR) of stroke and stroke subtypes by blood pressure category.
Blood pressure categories are baseline blood pressure category for incidence and incidence rate ratio (IRR) and time-updated mean blood pressure
category for HRs. Forest plot shows HRs and CIs. HRs and 95% CIs were estimated by Cox regression, adjusted for time-updated age, sex, stratified
by diabetes duration, being born in Sweden, maximum education level and baseline comorbidities (atrial fibrillation, coronary heart disease and
heart failure).

categories. This lower risk of haemorrhagic stroke offset the
increase in risk of ischaemic stroke and indicates that
individuals with Type 2 diabetes with a blood pressure
< 130/80 mmHg have a total stroke risk similar to that of
the general population.
Previous studies have found an approximately twofold
increased risk of stroke associated with Type 2 diabetes
[15,16]. We have not found any previous cohort study that
examined the excess risk of stroke in people with Type 2
diabetes at different blood pressure levels in comparison
with the general population. In a meta-analysis, Sarwar
et al. [15] found an increased risk of ischaemic stroke in
people with diabetes at all SBP levels compared with people
without diabetes, consistent with our findings regarding
ischaemic stroke. A synergistic effect between high glucose
levels and blood pressure that exponentially increases the
risk of cardiovascular disease has been previously observed
[17–19].
Earlier studies have differed concerning the relative risk of
haemorrhagic stroke in people with Type 2 diabetes, with
some studies indicating an increased risk [15,16], but not
others [4, 20]. Our finding of a lower risk of haemorrhagic
stroke in people with Type 2 diabetes, except in those with
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high blood pressure, could contribute to explaining these
divergent results. The most important risk factor for haemorrhagic stroke is blood pressure, where risk is increased
already in the upper-normal blood pressure range [4,21].
High total cholesterol and LDL cholesterol levels have been
found to reduce the risk of haemorrhagic stroke [4,22], and
high LDL cholesterol levels is one feature that characterizes
dyslipidaemia in people with Type 2 diabetes [23]; however,
studies with information on blood pressure levels as well as
other data in the general population are needed to further
elucidate the relationships between Type 2 diabetes, blood
pressure and stroke risk compared with the general population.
The present study has several strengths, including a large
number of diagnosed people with Type 2 diabetes and stroke
events, and data representative of people with Type 2
diabetes on routine treatment in hospital or primary care
centres nationwide. We have repeated measurements of
blood pressure and other risk factors in the Type 2 diabetes
group, as well as information on comorbidities and education for people with and without diabetes.
The study also has several limitations. First, and most
important, we did not have blood pressure measurements in
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FIGURE 2 Adjusted hazard ratios (HRs) for stroke in people with Type 2 diabetes compared with people without diabetes. HRs and 95% CIs were
estimated by means of Cox regression. Subgroup analyses by sex were adjusted for time-updated age, stratified by diabetes duration, being born in
Sweden, maximum education level and baseline comorbidities (atrial fibrillation, coronary heart disease and heart failure). Subgroup analyses by age
group were adjusted for sex, stratified by diabetes duration, being born in Sweden, maximum education level and baseline comorbidities (atrial
fibrillation, coronary heart disease and heart failure). Subgroup analyses by previous cardiovascular disease (CVD; ICD-10 I00-99) were adjusted for
sex, time-updated age, stratified by diabetes duration, being born in Sweden, and maximum education level. LCL, lower confidence limit; UCL,
upper confidence limit.

people without diabetes, and were unable to compare the
risk of stroke in people with and without diabetes at specific
blood pressure levels. However, the study design adds
information about the excess risk for people with Type 2
diabetes at different blood pressure levels compared with the
ª 2016 The Authors.
Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK

general population, which is relevant information not only to
the patients but also for the clinicians. Second, individuals
diagnosed with Type 2 diabetes but not included in the NDR
could be among the control population. The prevalence of
diabetes in Sweden is ~ 4% (NDR annual report 2013). The
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17 245/353 653
1.05 (0.81–1.36)
0.71
1.27 (1.12–1.44)
0.0002
1.00
1.14 (1.08–1.22)
< .0001
1.42 (1.34–1.50)
< .0001
2.00 (1.88–2.12)
< .0001
1.21 (1.19–1.22)
< .0001
1.17 (0.98–1.40)
0.086
1.16 (1.05–1.28)
0.0038
1.00
1.14 (1.07–1.21)
< .0001
1.41 (1.33–1.49)
< .0001
1.97 (1.85–2.09)
< .0001
1.20 (1.18–1.21)
< .0001
0.93 (0.87–0.99)
0.031
0.93 (0.88–0.99)
0.017
1.00
1.28 (1.23–1.32)
< .0001
1.76 (1.66–1.86)
< .0001
2.42 (2.16–2.72)
< .0001

18 598/393 425

1.12 (0.88–01.42)
0.34
1.25 (1.11–1.41)
0.0002
1.00
1.15 (1.08–1.21)
< .0001
1.43 (1.36–1.51)
< .0001
2.06 (1.95–2.18)
< .0001
1.22 (1.20–1.23)
< .0001
1.17 (0.99–1.39)
0.064
1.12 (1.01–1.23)
0.024
1.00
1.13 (1.07–1.20)
< .0001
1.41 (1.34–1.49)
< .0001
2.02 (1.91–2.14)
< .0001
1.18 (1.17–1.20)
< .0001

0.96 (0.90–1.02)
0.22
0.95 (0.90–1.01)
0.082
1.00
1.26 (1.22–1.30)
< .0001
1.74 (1.65–1.84)
< .0001
2.46 (2.21–2.74)
< .0001

Model B

0.88 (0.82–0.94)
0.0002
0.90 (0.85–0.96)
0.0006
1.00
1.30 (1.25–1.35)
< .0001
1.82 (1.72–1.92)
< .0001
2.51 (2.23–2.82)
< .0001

0.90 (0.69–1.17)
0.43
1.19 (1.05–1.35)
0.0065
1.00
1.18 (1.12–1.26)
< .0001
1.50 (1.42–1.59)
< .0001
2.14 (2.02–2.28)
< .0001
1.23 (1.22–1.25)
< .0001
1.01 (0.84–1.21)
0.94
1.10 (0.99–1.21)
0.070
1.00
1.17 (1.10–1.24)
< .0001
1.48 (1.40–1.56)
< .0001
2.09 (1.97–2.22)
< .0001
1.22 (1.20–1.24)
< .0001

16 778/346 672

Model C

0.89 (0.83–0.96)
0.0012
0.91 (0.86–0.96)
0.0011
1.00
1.28 (1.24–1.33)
< .0001
1.76 (1.66–1.86)
< .0001
2.34 (2.07–2.63)
< .0001

0.91 (0.70–1.18)
0.48
1.20 (1.06–1.36)
0.0036
1.00
1.18 (1.11–1.26)
< .0001
1.48 (1.40–1.57)
< .0001
2.08 (1.96–2.22)
< .0001
1.22 (1.20–1.24)
< .0001
1.01 (0.84–1.22)
0.89
1.10 (1.00–1.22)
0.055
1.00
1.17 (1.10–1.24)
< .0001
1.46 (1.38–1.54)
< .0001
2.04 (1.92–2.17)
< .0001
1.20 (1.19–1.22)
< .0001

16 604/342 984

Model D

0.96 (0.90–1.03)
0.29
0.96 (0.90–1.02)
0.16
1.00
1.20 (1.16–1.25)
< .0001
1.49 (1.40–1.59)
< .0001
1.75 (1.54–1.99)
< .0001

0.90 (0.68–1.18)
0.44
1.17 (1.03–1.33)
0.015
1.00
1.19 (1.11–1.26)
< .0001
1.50 (1.42–1.59)
< .0001
2.15 (2.01–2.29)
< .0001
1.17 (1.15–1.19)
< .0001
1.14 (0.94–1.38)
0.19
1.14 (1.03–1.27)
0.011
1.00
1.11 (1.05–1.19)
0.0006
1.33 (1.26–1.41)
< .0001
1.75 (1.64–1.88)
< .0001
1.12 (1.10–1.14)
< .0001

16 024/331 852

Model E

0.86 (0.78–0.95)
0.0034
0.91 (0.85–0.99)
0.024
1.00
1.22 (1.16–1.29)
< .0001
1.66 (1.50–1.85)
< .0001
1.93 (1.48–2.51)
< .0001

0.93 (0.63–1.39)
0.74
1.10 (0.92–1.32)
0.29
1.00
1.19 (1.10–1.30)
< .0001
1.43 (1.32–1.55)
< .0001
1.77 (1.62–1.95)
< .0001
1.18 (1.16–1.21)
< .0001
0.93 (0.69–1.25)
0.63
1.13 (0.98–1.30)
0.081
1.00
1.21 (1.11–1.31)
< .0001
1.43 (1.32–1.55)
< .0001
1.77 (1.61–1.94)
< .0001
1.18 (1.15–1.20)
< .0001

7554/236 160

Model F

0.86 (0.79–0.94)
0.0012
0.93 (0.86–0.99)
0.030
1.00
1.23 (1.18–1.29)
< .0001
1.71 (1.58–1.86)
< .0001
2.38 (1.99–2.85)
< .0001

0.92 (0.64–1.32)
0.65
1.28 (1.10–1.49)
0.0013
1.00
1.18 (1.10–1.28)
< .0001
1.48 (1.38–1.58)
< .0001
1.95 (1.80–2.11)
< .0001
1.21 (1.19–1.24)
< .0001
1.06 (0.83–1.35)
0.66
1.09 (0.97–1.24)
0.16
1.00
1.19 (1.10–1.28)
< .0001
1.46 (1.36–1.56)
< .0001
1.91 (1.77–2.07)
< .0001
1.19 (1.16–1.21)
< .0001

10 131/270 768

Model G

Model C (85.0% had no missing values): additionally adjusted for being born in Sweden, maximum education level and baseline comorbidities (atrial fibrillation, coronary heart disease and heart
failure).
Model D (84.0% had no missing values): Model C + adjusted for time-updated type of diabetic treatment and time-updated mean HbA1c.
Model E (81.3% had no missing values): Model C + adjusted for time-updated antihypertensive treatment and smoking and time-updated mean SBP/DBP
Model F (57.9% had no missing values): Model C + adjusted for time-updated mean BMI, time-updated physical activity, and renal impairment category.
Model G (66.4% had no missing values): Model C + adjusted for time-updated mean LDL and HDL cholesterol and triglyceride levels, and time-updated lipid-lowering medication.

DBP, diastolic blood pressure; SBP, systolic blood pressure.
HRs and CIs were estimated by means of Cox regression. The blood pressure category of 120–129/70–79 mmHg was used as a reference.
Model A (96.4% had no missing values): adjusted for time-updated age and sex.
Model B (86.7% had no missing values): additionally stratified by diabetes duration.

DBP ≥ 100 mmHg

DBP 90–99 mmHg

DBP 70–79 mmHg
DBP 80–89 mmHg

DBP 65–69 mmHg

Increased by 1 SD
mmHg diastolic
blood pressure
DBP < 65 mmHg

SBP ≥ 160 mmHg

SBP 140–159 mmHg

SBP 120–129 mmHg
SBP 130–139 mmHg

SBP 110–119 mmHg

Increased by 1 SD
mmHg SBP
SBP < 110 mmHg

≥ 160/≥ 100 mmHg

140–159/90–99 mmHg

120–129/70–79 mmHg
130–139/80–89 mmHg

110–119/65–69 mmHg

Stroke
n events/n individuals
< 110/< 65 mmHg

Model A

HR (95% CI) P value

Table 2 Adjusted hazard ratios for risk of stroke according to time-updated mean blood pressure categories among people with Type 2 diabetes
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percentage of all people with diabetes in Sweden included in
the NDR was estimated to 35–40% in 2006 and 88% in
2013 (NDR annual reports 2006 and 2013); therefore, even
if some individuals with Type 2 diabetes were included
among the controls, they will have been few and ought not to
have altered the association between blood pressure and
stroke in a decisive way. Third, there were missing data for
some variables in the NDR with only 57.9% of the original
cohort of people with Type 2 diabetes included in one of the
models; however, estimates of risk were not affected in a
manner that would alter our conclusions. Fourth, because of
the observational nature of the study we cannot eliminate the
possibility of residual confounding.
In conclusion, people with Type 2 diabetes as a group have
a moderately elevated risk of stroke, which is higher for
ischaemic than for haemorrhagic stroke. Even so, individuals
with Type 2 diabetes and a blood pressure < 130/80 mmHg
did not have a higher risk of any stroke compared with the
general population. These findings further emphasize the
importance of good blood pressure control in people with
Type 2 diabetes and indicate that they can have a risk of any
stroke that is similar to overall risk in the general population
if blood pressure is well controlled.
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